These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2570972)

  • 1. Clinical trials of zidovudine in HIV infection.
    Morris DJ
    Lancet; 1989 Sep; 2(8665):734. PubMed ID: 2570972
    [No Abstract]   [Full Text] [Related]  

  • 2. When should asymptomatic patients with HIV infection be treated with zidovudine?
    Gazzard BG
    BMJ; 1992 Feb; 304(6825):456-7. PubMed ID: 1347712
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?
    Ruedy J; Schechter M; Montaner JS
    Ann Intern Med; 1990 May; 112(10):721-3. PubMed ID: 1970465
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
    Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
    Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment for HIV: the time has come.
    Friedland GH
    N Engl J Med; 1990 Apr; 322(14):1000-2. PubMed ID: 1969114
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of zidovudine dosing.
    Stoukides CA; Cichocki TJ
    Ann Pharmacother; 1992 Jun; 26(6):784-5. PubMed ID: 1351766
    [No Abstract]   [Full Text] [Related]  

  • 8. The next step in AIDS treatment.
    Maddox J
    Nature; 1993 Apr; 362(6420):493. PubMed ID: 8096626
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection.
    Schulman KA; Lynn LA; Glick HA; Eisenberg JM
    Ann Intern Med; 1991 May; 114(9):798-802. PubMed ID: 1672806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine in asymptomatic HIV infection.
    Berger PB
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 7902534
    [No Abstract]   [Full Text] [Related]  

  • 11. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials: subgroup analyses.
    Stanley KE; Fischl MA; Collier AC
    Science; 1994 Aug; 265(5176):1158. PubMed ID: 7915047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes].
    Sarmati L; Vella S; Rocchi G
    Medicina (Firenze); 1990; 10(2):195-7. PubMed ID: 2273959
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy.
    Nye KE; Knox KA; Pinching AJ
    AIDS; 1991 Apr; 5(4):413-7. PubMed ID: 1676283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
    Ebert S; Gockel K; Horowitz S; Weber P; Vogelman B; Graziano F
    Wis Med J; 1991 Apr; 90(4):161-5. PubMed ID: 1675028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
    Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine for symptomless HIV infection.
    Lancet; 1990 Apr; 335(8693):821-2. PubMed ID: 1969561
    [No Abstract]   [Full Text] [Related]  

  • 20. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
    Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
    N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.